spacer
home > ict > winter 2009 > from dumb to smart
PUBLICATIONS
International Clinical Trials

From Dumb to Smart

BACKGROUND

The business fundamentals of conducting clinical research have changed dramatically over the last few years. Although not quite as well-publicised as the recent events in world financial markets, the fundamentals of the industry have steadily eroded. Clinical trials are more expensive, take longer to run, and patient recruitment is harder than ever, to give just a few examples.

Even more worrying is the fact that the industry has been content to operate in the dark, with few objective metrics about the convoluted internal operations critical to planning and conducting clinical trials. For example, the Six Sigma methodologies that can be applied to the clinical development process have only recently been recognised by the industry, despite the fact that Six Sigma provides objective criteria that helps to measure the value of decisions. These decisions commit hundreds of millions of dollars to development programmes.

Furthermore, job cuts are occurring with increasing regularity, as are dramatic outsourcing arrangements and billion-dollar acquisitions. Unfortunately, while these big announcements garner a lot of attention, the actions often obscure the need to improve the efficiency and effectiveness of day-to-day clinical operations. In fact, the decisions related to crucial development activities that determine the successes of specific clinical programmes and the overall health of the industry are often overlooked.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Edward Seguine is General Manager, Trial Planning Solutions, at Medidata Solutions, and is responsible for strategy development and execution. As a member of the senior management team at Medidata, Ed oversees all development, implementation and commercialisation activities for Medidata CRO Contractor, Medidata Designer, Medidata Grants Manager and the proprietary benchmark data these products rely on. Previously, Ed served as CEO of Fast Track Systems Inc, after moving from Eli Lilly, where he was instrumental in establishing both e.Lilly and Lilly Ventures. Ed is active in CDISC as the chair-elect of the Industry Advisory Board, a non-voting member of the CDISC board, and Financial Oversight Committee. In addition, he has written several articles and is a periodic speaker at industry events. Ed earned his BBA from Brigham Young University and MBA from Indiana University.
spacer
Edward Seguine
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sepha Introduces Newly Patented 3D Leak Detection Technology For Blister Packs

Belfast, UK, November 30, 2020: Sepha, specialist in leak test solutions for the pharmaceutical packaging industry, will be introducing its newly patented 3D Leak Detection technology for pharmaceutical blister packs via two live online webinars on the 2nd and 3rd December 2020. Aimed at pharmaceutical manufacturers, the new technology incorporates a 3D sensor to provide volumetric measurement to assess the integrity of a range of pharmaceutical solid dose and flexible barrier packaging.
More info >>

White Papers

Stripping the confusion out of PVC curtains... and a new seat range.

Teknomek Ltd

With the ever-growing trend towards modularisation of clean rooms and laboratories; Teknomek have responded with a new range of PVC strip curtains, suitable for use in environments where maintaining clean airflow is critical. This new PVC curtain range includes specialist perforated and electrostatic discharge alternatives to the standard options of clear and polar (-25oC) versions.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement